6th Dermatology Drug Development Summit Europe
Tuesday, May 27, 2025 -- Wednesday, May 28, 2025, 0800 - 1615
The Dermatology Drug Development Summit Europe returns for its 6th year as the premier industry forum dedicated to advancing next-generation immunodermatology therapies. With regulatory breakthroughs reshaping the landscape-such as Eli Lilly’s IL-13 inhibitor and LEO Pharma’s topical JAK-I-2024 was a pivotal year for the industry to accelerate innovation.
Join 80+ senior leaders from Sanofi, Alys Pharmaceuticals, Moonlake Immunotherapeutics, and more to ensure 2025 breaks new records for the industry!
Get stuck into topics such as:
- Explore novel clinical and preclinical candidate data to produce best-in-class drugs for diverse indications
- Understand contemporary indication expansion strategies to maximise the value of your pipeline and diversify your immuno-inflammatory portfolio
- Collaborate with peers to accelerate trial timelines, optimize endpoint strategies, and enhance clinical data quality to fast track regulatory approval
URLs:
Website: https://go.evvnt.com/2918020-0?pid=2874
Brochure: https://go.evvnt.com/2918020-3?pid=2874
Category: Conferences | Science, Health & Medicine | Pharmaceuticals
Prices:
Conference Only - Industry Pricing: EUR 2799.00,
Conference Only - Academic Pricing: EUR 2399.00,
Conference Only - Vendor Pricing: EUR 3499.00
Speakers: Ana Rossi, Global Senior Medical Director, Immunology, Sanofi, Carlo Pincelli, Chief Medical Officer, PinCell, Cheri Ackerman, Co-Founder and CEO, Concerto Biosciences, Daniel Brownell, Senior Director, R AND D, AOBiome, Ehsanollah Esfandiari, Global Head, Immunology R AND D, Kyowa Kirin, Eric Meldrum, Chief Scientific Officer, Citryll Therapeutics, Hana Cernecka, Managing director, EB Research Institute, Hannah Cummings, Senior Director, Medical Affairs, Kyowa Kirin, Kristian Reich, Co-Founder and Chief Scientific Officer, MoonLake, Lars French, Chief Medical Officer, Alys Pharmaceuticals, Luis F. Santamaria-Babí, Full Professor of Clinical and Translational Immunology, University of Barcelona, Mike Davies, Chief Executive Officer, Carocell Bio, Niels Riedemann, Chief Executive Officer, Inflarx, Serena Mandla, Co-Founder and Chief Scientific Officer, Noa Therapeutics, Simmi Wiggins, Global Lead, Immunology and Medical, Sanofi, Verena Hultsch, Global Medical Affairs, Dermatology - Bullous Pemphigoid, Sanofi
Join 80+ senior leaders from Sanofi, Alys Pharmaceuticals, Moonlake Immunotherapeutics, and more to ensure 2025 breaks new records for the industry!
Get stuck into topics such as:
- Explore novel clinical and preclinical candidate data to produce best-in-class drugs for diverse indications
- Understand contemporary indication expansion strategies to maximise the value of your pipeline and diversify your immuno-inflammatory portfolio
- Collaborate with peers to accelerate trial timelines, optimize endpoint strategies, and enhance clinical data quality to fast track regulatory approval
URLs:
Website: https://go.evvnt.com/2918020-0?pid=2874
Brochure: https://go.evvnt.com/2918020-3?pid=2874
Category: Conferences | Science, Health & Medicine | Pharmaceuticals
Prices:
Conference Only - Industry Pricing: EUR 2799.00,
Conference Only - Academic Pricing: EUR 2399.00,
Conference Only - Vendor Pricing: EUR 3499.00
Speakers: Ana Rossi, Global Senior Medical Director, Immunology, Sanofi, Carlo Pincelli, Chief Medical Officer, PinCell, Cheri Ackerman, Co-Founder and CEO, Concerto Biosciences, Daniel Brownell, Senior Director, R AND D, AOBiome, Ehsanollah Esfandiari, Global Head, Immunology R AND D, Kyowa Kirin, Eric Meldrum, Chief Scientific Officer, Citryll Therapeutics, Hana Cernecka, Managing director, EB Research Institute, Hannah Cummings, Senior Director, Medical Affairs, Kyowa Kirin, Kristian Reich, Co-Founder and Chief Scientific Officer, MoonLake, Lars French, Chief Medical Officer, Alys Pharmaceuticals, Luis F. Santamaria-Babí, Full Professor of Clinical and Translational Immunology, University of Barcelona, Mike Davies, Chief Executive Officer, Carocell Bio, Niels Riedemann, Chief Executive Officer, Inflarx, Serena Mandla, Co-Founder and Chief Scientific Officer, Noa Therapeutics, Simmi Wiggins, Global Lead, Immunology and Medical, Sanofi, Verena Hultsch, Global Medical Affairs, Dermatology - Bullous Pemphigoid, Sanofi
Starting Price Per Person
€ 2399.00 EUR
Other Information
Where
Hotel Palace Berlin
45 Budapester Straße
Berlin 10787
Germany
( Hotel - Resort )
45 Budapester Straße
Berlin 10787
Germany
( Hotel - Resort )
Event Organizer Contact
More Events
Event ID: 247614
Get Events in Your Inbox
We have over 100,000 Events in 80+ Categories. Tell us what type of events you like, and we will send them to your inbox